Pascal Paubel
Impact in
-
- Epilepsy research and treatment
-
- Pharmaceutical studies and practices
- Pharmacological Effects and Toxicity Studies
Papers in
-
- Pharmaceutical Economics and Policy 17
- Health Systems, Economic Evaluations, Quality of Life 17
- Economic and Financial Impacts of Cancer 3
-
- Pharmaceutical Practices and Patient Outcomes 6
- Co-authors
- Marie‐Liesse Piketty (3 shared papers)François C. Bocquet (8 shared papers)Claude Le Pen (3 shared papers)Elisabeth Landré (1 shared paper)Francine Chassoux (1 shared paper)Yves Contejean (2 shared papers)Kelley Kaye (2 shared papers)Catherine Doyen (1 shared paper)
In The Last Decade
Pascal Paubel
39 papers receiving 315 citations
Peers
Comparison fields: 5 of 71
- Psychiatry and Mental health 75
- Pediatrics, Perinatology and Child Health 61
- Analytical Chemistry 32
- Economics and Econometrics 86
- Immunology 62
Countries citing papers authored by Pascal Paubel
This map shows the geographic impact of Pascal Paubel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Paubel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Paubel more than expected).
Fields of papers citing papers by Pascal Paubel
This network shows the impact of papers produced by Pascal Paubel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Paubel. The network helps show where Pascal Paubel may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Paubel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 60 | |
| 2 | 2011 | 42 | |
| 3 | 2008 | 31 | |
| 4 | 2017 | 19 | |
| 5 | 2013 | 18 | |
| 6 | 2014 | 18 | |
| 7 | 2014 | 17 | |
| 8 | 2015 | 16 | |
| 9 | 2016 | 14 | |
| 10 | 2016 | 11 | |
| 11 | 2012 | 10 | |
| 12 | 2023 | 8 | |
| 13 | 2008 | 6 | |
| 14 | 2023 | 6 | |
| 15 | 2010 | 4 | |
| 16 | 2016 | 4 | |
| 17 | 2018 | 4 | |
| 18 | 2023 | 4 | |
| 19 | 2016 | 3 | |
| 20 | 2018 | 3 |
About Pascal Paubel
Pascal Paubel is a scholar working on Economics and Econometrics, Geriatrics and Gerontology, Immunology, General Health Professions and Psychiatry and Mental health, having authored 56 papers that have together received 326 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (17 papers), Health Systems, Economic Evaluations, Quality of Life (17 papers), Biosimilars and Bioanalytical Methods (10 papers), Healthcare Systems and Practices (8 papers), Pharmaceutical Practices and Patient Outcomes (6 papers), Economic and Financial Impacts of Cancer (3 papers), Sarcoma Diagnosis and Treatment (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Psychiatry and Mental health (75 citations), Pediatrics, Perinatology and Child Health (61 citations), Analytical Chemistry (32 citations), Economics and Econometrics (86 citations) and Immunology (62 citations). Pascal Paubel has collaborated with scholars based in France, Canada and Australia. Frequent co-authors include Marie‐Liesse Piketty, François C. Bocquet, Claude Le Pen, Elisabeth Landré, Francine Chassoux, Yves Contejean, Kelley Kaye, Catherine Doyen, Jean‐Pierre Lotz and Claude Le Pen. Their work appears in journals such as Value in Health, Applied Health Economics and Health Policy, PharmacoEconomics, Health Policy and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.